- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
TP53-binding protein variants and breast cancer risk: a case-control study ; volume:7 ; number:4 ; day:6 ; month:5 ; year:2005 ; pages:1-4 ; date:8.2005
Breast cancer research ; 7, Heft 4 (6.5.2005), 1-4, 8.2005
- Urheber
-
Frank, Bernd
- Beteiligte Personen und Organisationen
-
Hemminki, Kari
Bermejo, Justo Lorenzo
Klaes, Rüdiger
Bugert, Peter
Wappenschmidt, Barbara
Schmutzler, Rita K.
Burwinkel, Barbara
SpringerLink (Online service)
- DOI
-
10.1186/bcr1038
- URN
-
urn:nbn:de:1111-2016032356369
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Frank, Bernd
- Hemminki, Kari
- Bermejo, Justo Lorenzo
- Klaes, Rüdiger
- Bugert, Peter
- Wappenschmidt, Barbara
- Schmutzler, Rita K.
- Burwinkel, Barbara
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population
BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study
MUTYH gene variants and breast cancer in a Dutch case–control study
Impact of TP53 mutations in Triple Negative Breast Cancer
Clinical implications of germline mutations in breast cancer: TP53
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
Germline TP53 mutational spectrum in French Canadians with breast cancer
The R337H mutation in TP53 and breast cancer in Brazil
Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility
In cis TP53 and RAD51C pathogenic variants may predispose to sebaceous gland carcinomas
Correction: Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility
Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population
BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study
MUTYH gene variants and breast cancer in a Dutch case–control study
Impact of TP53 mutations in Triple Negative Breast Cancer
Clinical implications of germline mutations in breast cancer: TP53
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
Germline TP53 mutational spectrum in French Canadians with breast cancer
The R337H mutation in TP53 and breast cancer in Brazil
Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility
In cis TP53 and RAD51C pathogenic variants may predispose to sebaceous gland carcinomas
Correction: Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility
Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population
BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study
MUTYH gene variants and breast cancer in a Dutch case–control study
Impact of TP53 mutations in Triple Negative Breast Cancer
Clinical implications of germline mutations in breast cancer: TP53
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
Germline TP53 mutational spectrum in French Canadians with breast cancer
The R337H mutation in TP53 and breast cancer in Brazil
Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility
In cis TP53 and RAD51C pathogenic variants may predispose to sebaceous gland carcinomas